TA-1801
Names
Biological Activity
[Description]:
TA-1801 is a hypolipidemic agent.
[Related Catalog]:
[In Vitro]
TA-1801 inhibits platelet aggregation in vitro[1].
[In Vivo]
TA-1801 reduces serum cholesterol and triglyceride levels by 23% and 35%, respectively, at a dose of 0.05% in a diet in normal rats, and it is about 10 times more active in hereditary hyperlipidemic rats (THLR/1) than in normal rats[1].
[References]
[Related Small Molecules]
Captisol
|
Cyclosporin A
|
H2DCFDA
|
0MPTP hydrochloride
|
GW4869
|
Etomoxir
|
TD139
|
Mitoquinone mesylate
|
GSK2795039
|
JC-1
|
BAPTA-AM
|
AP 20187
|
Setanaxib (GKT137831)
|
D-Luciferin
|
Crotaline
Chemical & Physical Properties
[ Density]:
1.275g/cm3
[ Boiling Point ]:
471ºC at 760 mmHg
[ Molecular Formula ]:
C17H14ClNO4
[ Molecular Weight ]:
331.75000
[ Flash Point ]:
238.6ºC
[ Exact Mass ]:
331.06100
[ PSA ]:
65.47000
[ LogP ]:
4.36060
[ Index of Refraction ]:
1.556
[ Storage condition ]:
2-8℃
Synthetic Route
Precursor & DownStream
Precursor
DownStream
Related Compounds
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.